Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma
NCT01086488
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
66
Enrollment
OTHER_GOV
Sponsor class
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
FOSCAN
Sponsor
Ministry of Health, Malaysia